HealthEquity, Inc. $HQY Shares Bought by Econ Financial Services Corp

Econ Financial Services Corp grew its holdings in shares of HealthEquity, Inc. (NASDAQ:HQYFree Report) by 39.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 27,249 shares of the company’s stock after buying an additional 7,770 shares during the period. Econ Financial Services Corp’s holdings in HealthEquity were worth $2,496,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also made changes to their positions in HQY. Three Seasons Wealth LLC raised its position in shares of HealthEquity by 49.8% during the 4th quarter. Three Seasons Wealth LLC now owns 5,521 shares of the company’s stock worth $506,000 after acquiring an additional 1,836 shares in the last quarter. Private Advisory Group LLC boosted its holdings in HealthEquity by 6.2% in the fourth quarter. Private Advisory Group LLC now owns 101,382 shares of the company’s stock valued at $9,288,000 after purchasing an additional 5,875 shares in the last quarter. Chesley Taft & Associates LLC boosted its holdings in HealthEquity by 4.5% in the fourth quarter. Chesley Taft & Associates LLC now owns 26,399 shares of the company’s stock valued at $2,418,000 after purchasing an additional 1,139 shares in the last quarter. Exchange Traded Concepts LLC purchased a new position in HealthEquity in the fourth quarter valued at approximately $94,000. Finally, Curated Wealth Partners LLC increased its stake in HealthEquity by 24.3% in the fourth quarter. Curated Wealth Partners LLC now owns 3,267 shares of the company’s stock valued at $299,000 after purchasing an additional 639 shares during the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $83.57 on Wednesday. The company has a current ratio of 3.27, a quick ratio of 3.27 and a debt-to-equity ratio of 0.45. HealthEquity, Inc. has a twelve month low of $72.76 and a twelve month high of $116.65. The stock has a 50 day moving average of $79.95 and a two-hundred day moving average of $89.52. The stock has a market cap of $7.06 billion, a P/E ratio of 33.97, a P/E/G ratio of 1.48 and a beta of 0.26.

HealthEquity (NASDAQ:HQYGet Free Report) last announced its earnings results on Tuesday, March 17th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.05. The business had revenue of $334.59 million for the quarter, compared to analyst estimates of $332.48 million. HealthEquity had a net margin of 16.39% and a return on equity of 13.86%. The firm’s revenue for the quarter was up 7.3% on a year-over-year basis. On average, research analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on HQY shares. Barrington Research reduced their price objective on shares of HealthEquity from $125.00 to $110.00 and set an “outperform” rating for the company in a research report on Wednesday, March 18th. BMO Capital Markets reaffirmed a “market perform” rating on shares of HealthEquity in a research report on Wednesday, March 18th. Barclays cut their price target on shares of HealthEquity from $118.00 to $110.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 18th. The Goldman Sachs Group cut shares of HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 price target for the company. in a research report on Friday, January 9th. Finally, Royal Bank Of Canada decreased their price objective on shares of HealthEquity from $110.00 to $100.00 and set an “outperform” rating for the company in a research note on Wednesday, March 18th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $110.36.

View Our Latest Report on HealthEquity

HealthEquity Company Profile

(Free Report)

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

Further Reading

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYFree Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.